Literature DB >> 23574323

Dual role of interleukin-10 in the regulation of respiratory syncitial virus (RSV)-induced lung inflammation.

L Sun1, T T Cornell, A LeVine, A A Berlin, V Hinkovska-Galcheva, A J Fleszar, N W Lukacs, T P Shanley.   

Abstract

RSV lower respiratory tract infections (LRTI) are among the most common diseases necessitating hospital admission in children. In addition to causing acute respiratory failure, RSV infections are associated with sequelae such as secondary bacterial infections and reactive airway disease. One characteristic host response observed in severe RSV-induced LRTI and/or subsequent development of asthma is increased expression of interleukin (IL)-10. However, contradictory results have been reported regarding whether IL-10 inhibits asthmatic responses or intensifies the disease. We aimed to reconcile these discordant observations by elucidating the role of IL-10 in regulating the host response to RSV LRTI. In this study, we used a lung-specific, inducible IL-10 over-expression (OE) transgenic mouse model to address this question. Our results showed that the presence of IL-10 at the time of RSV infection not only attenuated acute inflammatory process (i.e. 24 h post-infection), but also late inflammatory changes [characterized by T helper type 2 (Th2) cytokine and chemokine expression]. While this result appears contradictory to some clinical observations where elevated IL-10 levels are observed in asthmatic patients, we also found that delaying IL-10 OE until the late immune response to RSV infection, additive effects rather than inhibitory effects were observed. Importantly, in non-infected, IL-10 OE mice, IL-10 OE alone induced up-regulation of Th2 cytokine (IL-13 and IL-5) and Th2-related chemokine [monocyte chemoattractant protein 1 (MCP-1), chemokine (C-C motif) ligand 3 (CCL3) and regulated upon activation normal T cell expressed and secreted (RANTES)] expression. We identified a subset of CD11b(+)CD11c(+)CD49b(+)F4/80(-)Gr-1(-) myeloid cells as a prinicipal source of IL-10-induced IL-13 production. Therefore, the augmented pathological responses observed in our 'delayed' IL-10 over-expression model could be attributed to IL-10 OE alone. Taken together, our study indicated dual roles of IL-10 on RSV-induced lung inflammation which appear to depend upon the timing of when elevated IL-10 is expressed in the lung.
© 2012 British Society for Immunology.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23574323      PMCID: PMC3628329          DOI: 10.1111/cei.12059

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  54 in total

1.  Interleukin (IL) 4 and IL-13 act on human lung fibroblasts. Implication in asthma.

Authors:  C Doucet; D Brouty-Boyé; C Pottin-Clémenceau; G W Canonica; C Jasmin; B Azzarone
Journal:  J Clin Invest       Date:  1998-05-15       Impact factor: 14.808

2.  Monocyte IL-10 production during respiratory syncytial virus bronchiolitis is associated with recurrent wheezing in a one-year follow-up study.

Authors:  L Bont; C J Heijnen; A Kavelaars; W M van Aalderen; F Brus; J T Draaisma; S M Geelen; J L Kimpen
Journal:  Am J Respir Crit Care Med       Date:  2000-05       Impact factor: 21.405

3.  Respiratory syncytial virus (RSV) infection induces cyclooxygenase 2: a potential target for RSV therapy.

Authors:  Joann Y Richardson; Martin G Ottolini; Lioubov Pletneva; Marina Boukhvalova; Shuling Zhang; Stefanie N Vogel; Gregory A Prince; Jorge C G Blanco
Journal:  J Immunol       Date:  2005-04-01       Impact factor: 5.422

4.  Relationship between atopic status and nasal interleukin 10 and 11 levels in infants with respiratory syncytial virus bronchiolitis.

Authors:  Hai Lee Chung; Woo Taek Kim; Jin Kyung Kim; Eun Jin Choi; Jun Hwa Lee; Gyeong Hoon Lee; Sang Gyung Kim
Journal:  Ann Allergy Asthma Immunol       Date:  2005-02       Impact factor: 6.347

Review 5.  Childhood viral infection and the pathogenesis of asthma and chronic obstructive lung disease.

Authors:  J C Hogg
Journal:  Am J Respir Crit Care Med       Date:  1999-11       Impact factor: 21.405

6.  Treatment of murine colitis by Lactococcus lactis secreting interleukin-10.

Authors:  L Steidler; W Hans; L Schotte; S Neirynck; F Obermeier; W Falk; W Fiers; E Remaut
Journal:  Science       Date:  2000-08-25       Impact factor: 47.728

7.  Efficacy and safety studies of a recombinant chimeric respiratory syncytial virus FG glycoprotein vaccine in cotton rats.

Authors:  G A Prince; C Capiau; M Deschamps; L Fabry; N Garçon; D Gheysen; J P Prieels; G Thiry; O Van Opstal; D D Porter
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

8.  Interleukin-10 level in sputum is reduced in bronchial asthma, COPD and in smokers.

Authors:  S Takanashi; Y Hasegawa; Y Kanehira; K Yamamoto; K Fujimoto; K Satoh; K Okamura
Journal:  Eur Respir J       Date:  1999-08       Impact factor: 16.671

9.  Immunoregulatory effects of regulated, lung-targeted expression of IL-10 in vivo.

Authors:  Donn Spight; Bin Zhao; Michael Haas; Susan Wert; Alvin Denenberg; Thomas P Shanley
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2004-10-01       Impact factor: 5.464

10.  Interleukin-25 induces type 2 cytokine production in a steroid-resistant interleukin-17RB+ myeloid population that exacerbates asthmatic pathology.

Authors:  Bryan C Petersen; Alison L Budelsky; Alan P Baptist; Matthew A Schaller; Nicholas W Lukacs
Journal:  Nat Med       Date:  2012-05       Impact factor: 53.440

View more
  20 in total

1.  Infant Viral Respiratory Infection Nasal Immune-Response Patterns and Their Association with Subsequent Childhood Recurrent Wheeze.

Authors:  Kedir N Turi; Jyoti Shankar; Larry J Anderson; Devi Rajan; Kelsey Gaston; Tebeb Gebretsadik; Suman R Das; Cosby Stone; Emma K Larkin; Christian Rosas-Salazar; Steven M Brunwasser; Martin L Moore; R Stokes Peebles; Tina V Hartert
Journal:  Am J Respir Crit Care Med       Date:  2018-10-15       Impact factor: 21.405

2.  Association between interleukin-10 genetic polymorphisms and risk of primary open angle glaucoma in a Chinese Han population: a case-control study.

Authors:  Yi-Hui Zhang; Yi-Qiao Xing; Zhen Chen; Xiao-Cheng Ma; Qiang Lu
Journal:  Int J Ophthalmol       Date:  2019-10-18       Impact factor: 1.779

3.  Polymorphisms in the promoter region of IL10 gene are associated with virus etiology of infant bronchiolitis.

Authors:  Annukka Holster; Johanna Teräsjärvi; Juho Vuononvirta; Petri Koponen; Ville Peltola; Merja Helminen; Qiushui He; Matti Korppi; Kirsi Nuolivirta
Journal:  World J Pediatr       Date:  2018-05-25       Impact factor: 2.764

4.  Interleukin 10 overexpression alters survival in the setting of gram-negative pneumonia following lung contusion.

Authors:  Vladislav A Dolgachev; Bi Yu; Lei Sun; Thomas P Shanley; Krishnan Raghavendran; Mark R Hemmila
Journal:  Shock       Date:  2014-04       Impact factor: 3.454

5.  The protective effect of Shenfu injection against elderly severe pneumonia.

Authors:  S J Lv; D P Lai; X Wei; Q Yan; J M Xia
Journal:  Eur J Trauma Emerg Surg       Date:  2016-07-25       Impact factor: 3.693

6.  Neonatal respiratory syncytial virus infection has an effect on lung inflammation and the CD4(+) CD25(+) T cell subpopulation during ovalbumin sensitization in adult mice.

Authors:  A Comas-García; C P López-Pacheco; E A García-Zepeda; G Soldevila; P Ramos-Martínez; J Ramos-Castañeda
Journal:  Clin Exp Immunol       Date:  2016-05-12       Impact factor: 4.330

7.  Prednisolone as preservation additive prevents from ischemia reperfusion injury in a rat model of orthotopic lung transplantation.

Authors:  Patrick Paulus; Johannes Holfeld; Anja Urbschat; Haitham Mutlak; Pia Alexandra Ockelmann; Sabine Tacke; Kai Zacharowski; Christin Reissig; David Stay; Bertram Scheller
Journal:  PLoS One       Date:  2013-08-29       Impact factor: 3.240

8.  Major and minor group rhinoviruses elicit differential signaling and cytokine responses as a function of receptor-mediated signal transduction.

Authors:  Bryce A Schuler; Michael T Schreiber; Luyuan Li; Michal Mokry; Megan L Kingdon; Dana N Raugi; Cosonya Smith; Chelsea Hameister; Vincent R Racaniello; David J Hall
Journal:  PLoS One       Date:  2014-04-15       Impact factor: 3.240

9.  Matrix protein CCN1 induced by bacterial DNA and CpG ODN limits lung inflammation and contributes to innate immune homeostasis.

Authors:  H-G Moon; Z Qin; T Quan; L Xie; C S Dela Cruz; Y Jin
Journal:  Mucosal Immunol       Date:  2014-07-09       Impact factor: 7.313

10.  Plasma Inflammatory Cytokine IL-4, IL-8, IL-10, and TNF-α Levels Correlate with Pulmonary Function in Patients with Asthma-Chronic Obstructive Pulmonary Disease (COPD) Overlap Syndrome.

Authors:  Ai-Xia Huang; Li-Wen Lu; Wen-Juan Liu; Mao Huang
Journal:  Med Sci Monit       Date:  2016-08-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.